Taylor Swift Dominates, LabCorp Expands & Red Lobster Adds Surf
LabCorp will buy Covance to improve its clinical trial research for pharmaceuticals, and Taylor Swift's new album has the biggest release for an artist since 2002.
LabCorp said Monday it will pay $6.1 billion in cash and stock, or $105.12 per share, to buy Covance to improve its clinical trial research for pharmaceuticals. The medical testing company’s offer represents a 32% premium to Covance's previous closing price. Meanwhile, Red Lobster said Monday it is adding extra surf to its menu and reducing the turf. The chain's new management is raising the seafood portion of the menu to 85% from 75% after its previous owner scaled it back. Finally, Taylor Swift is dominating the music business again. Her new album ‘1989’ sold 1.3 million copies in its first week of release, making it the biggest debut for an artist since 2002.
